SPI Infoamtion

このレポートは章ごとの個別販売も行っておりますのでお問い合わせ下さい。
※全てPDFでの販売となります。

Chapter- 1: INTRODUCTION

STUDY GOAL AND OBJECTIVES
REASONS FOR DOING THE STUDY
INTENDED AUDIENCE
SCOPE OF REPORT
METHODOLOGY
INFORMATION SOURCES
AUTHOR’S CREDENTIALS
RELATED BCC PUBLICATIONS
BCC ONLINE SERVICES
DISCLAIMER

Chapter-2: SUMMARY

DECISIVE CHANGES IN LIVES
WHAT DOES THE FUTURE HOLD?
PROJECTIONS FOR FUTURE NEEDS
SUMMARY TABLE PROJECTED NEEDS OF THE U.S. ELDERLY, THROUGH 2014 ($ MILLIONS)
SUMMARY FIGURE PROJECTED NEEDS OF THE U.S. ELDERLY, BY MARKET SEGMENT, 2008-2014 ($ MILLIONS)
SOURCE: BCC RESEARCH

Chapter-3: DEMOGRAPHICS OF THE ELDERCARE MARKET

DEFINITIONS
GLOBAL SOCIAL ENVIRONMENT
INTERGENERATIONAL LIVING ISSUES IN DEVELOPING COUNTRIES
INTERGENERATIONAL-LIVING ISSUES IN DEVELOPED COUNTRIES
GLOBAL ECONOMIC ENVIRONMENT
DEMOGRAPHICS IN THE UNITED STATES
SHIFTING DEMOGRAPHICS IN THE U.S.
TABLE 1 ESTIMATES FOR OVER-65 POPULATIONS BY U.S. REGION, 2007
RACIAL AND ETHNIC CHANGES
FIGURE 1 DISTRIBUTION OF OVER-65 U.S POPULATION BY RACE/ETHNICITY 2007 AND 2015 (%)
HEALTH OF THE ELDERLY IN THE U.S.
DISCREPANCIES IN MINORITY HEALTH STATUS
LIVING WITH LIMITATIONS
FIGURE 2 PREVALANCE OF CHRONIC CONDITIONS AMONG ADULTS IN THE U.S. OVER 65 YEARS OF AGE, BY RACE AND ETHNICITY (%)
FIGURE 3 CHRONIC CONDITIONS IN U.S. POPULATION OVER 65, 2005 (%)
LONG-TERM CARE SPENDING
FIGURE 4 U.S. NATIONAL SPENDING ON LONG-TERM CARE, BY PAYER, 2005 (%)
U.S. HEALTH TRENDS
TABLE 2 MOST COMMON CHRONIC CONDITIONS BY AGE, GENDER, AND RACE IN U.S., 2005
MORTALITY AND U.S. SENIORS
FIGURE 5 LEADING CAUSES OF U.S. DEATHS IN THOSE OVER 65, 2007 (%)
INDIVIDUAL BEHAVIORS AND MORTALITY
ECONOMIC TRENDS FOR U.S. SENIORS
HOUSING TRENDS FOR U.S. SENIORS
Housing Options
LIFESTYLE TRENDS FOR SENIORS IN THE U.S.
INTERNATIONAL DEMOGRAPHICS
HEALTH OF THE ELDERLY AROUND THE GLOBE
ECONOMIC TRENDS OUTSIDE THE U.S.
HOUSING TRENDS OUTSIDE THE U.S.
GLOBAL LIFESTYLE TRENDS OF THE ELDERLY

Chapter-4: OVERVIEW OF HEALTHCARE FUNDING POSSIBILITIES

U. S. AND INTERNATIONAL HEALTHCARE COSTS
TABLE 3 COMPARISON OF ESTIMATED GOVERNMENT HEALTHCARE SPENDING AS PERCENT OF GDP, 2007 (%/$ MILLIONS))
FIGURE 6 PROJECTED U.S. POPULATION OVER 65, 2000-2050 (%)
U.S. RETIREMENT FUNDING
Individual Retirement Savings
Social Security
FIGURE 7 RECIPIENTS OF SOCIAL SECURITY BENEFITS, 2006 (%)
Social Security Beneficiaries
Social Security Solvency
Company-sponsored Pension Plans
GLOBAL RETIREMENT FUNDING
Individual Retirement Savings
TABLE 4 SELECTED PUBLIC AND PRIVATE PENSION EXPENDITURES, 2006 ($ MILLIONS)
Social Security
TYPES OF HEALTHCARE FUNDING IN THE U.S.
Private Insurance
Long Term Care Insurance
Medicare
Medicare Part A
Medicare Part B
Medicare Part C
Medicare Part D
Medicaid
Medicaid Spending and Community-based Services
TABLE 5 CURRENT MEDICARE/MEDICAID PAYMENTS FOR SERVICES, 2009
Medicare and Private Health Insurance Reimbursement Issues
Medicare Policies on Reimbursement for Powered Wheelchairs

Chapter-5: U.S. GOVERNMENT PROGRAMS AND LEGISLATION FOR THE ELDERLY

THE AMERICANS WITH DISABILITIES ACT
LITIGATION ON BEHALF OF THE ELDERLY
ADDITIONAL LEGISLATION
SAFETY AND QUALITY REGULATIONS
CLASS I AND II DEVICES
NUTRITION PROGRAMS
INFRASTRUCTURE CONSIDERATIONS

Chapter-6: INDUSTRY TRENDS BY SECTOR―HEALTHCARE

INDUSTRY TRENDS BY SECTOR―HEALTHCARE
TABLE 6 PROJECTED U.S. MARKET FOR ELDERCARE HEALTHCARE PRODUCTS AND SERVICES, THROUGH 2014 ($ MILLIONS)
ARTHRITIS
TABLE 7 INCIDENCE OF DIAGNOSED ARTHRITIS CASES AND CHRONIC JOINT SYMPTOMS IN THE U.S. BY AGE GROUP, 2006 (MILLION PERSONS)
Current Treatments
Medications
・ Rheumatoid Arthritis
・ Anticytokine Agents
TABLE 8 NEWER ANTICYTOKINE AGENTS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
Nutritional Supplements
Future Arthritis Burden in the U.S.
FIGURE 8 FUTURE BURDEN OF ARTHRITIS FOR THOSE OVER 65 IN THE U.S., BY GENDER, 2010-2030 (MILLIONS)
Market for Treatments for Arthritis for the Elderly
TABLE 9 PROJECTED U.S. MARKET FOR PHARMACEUTICAL ARTHRITIS MEDICATIONS FOR INDIVIDUALS OVER 65, AT MANUFACTURER’S COST, THROUGH 2014 ($ MILLIONS)
Opportunities for Growth Related to Arthritis
CARDIOVASCULAR DISEASES
Cardiovascular Disease in the U.S.
Cardiovascular Disease Internationally
Risk Factors
Treatments
Lifestyle Changes
Medications
TABLE 10 SELECTED HEART DISEASE MEDICATIONS
TABLE 11 GLOBAL MARKET FOR CARDIOVASCULAR DISEASE MEDICATIONS, THROUGH 2014 ($ MILLIONS)
TABLE 12 U.S. MARKET FOR CARDIOVASCULAR DISEASE MEDICATIONS FOR THE ELDERLY, THROUGH 2014 ($ MILLIONS)
Surgery
TABLE 13 U.S. MARKET FOR CARDIOVASCULAR SURGICAL PROCEDURES FOR THE ELDERLY, THROUGH 2014 ($ MILLIONS)
NEUROLOGICAL DYSFUNCTIONS
Related Dementias and Alzheimer’s Disease
FIGURE 9 CAUSES OF DEMENTIA IN PEOPLE OVER 65 (%)
Current Treatments for Alzheimer’s
TABLE 14 COMMON PRESCRIPTION MEDICATIONS TO TREAT ALZHEIMER’S DISEASE
DEPRESSION
Origins of the Disease
Genetic Factors
Biological Factors
Sociological Factors
Psychological Factors
Risk Factors for Depression
Gender
Age
Marital status
Family History
Social Support
Family Type
Medical Status
TABLE 15 PERCENTAGE OF PATIENTS WHO REPORT BEING DEPRESSED, BY CHRONIC CONDITION (%)
Types of Depression
Prevalence of the Disorder
Diagnosing Depression
Treatment for Depression
TABLE 16 GLOBAL DIRECT AND INDIRECT COST OF DEPRESSION, THROUGH 2014 ($ MILLIONS)
Therapy
Antidepressant Medications
TABLE 17 SELECTED ANTIDEPRESSANT MEDICATIONS
・ Market for Neurological Medications
TABLE 18 PROJECTED U.S. MARKET FOR DEMENTIA AND DEPRESSION MEDICATIONS FOR THE ELDERLY, THROUGH 2014 ($ MILLIONS)
CANCER
Types of Cancer
FIGURE 10 ESTIMATED NEW CASES OF CANCER IN THE U.S., 2008 (%)
Costs for Cancer
TABLE 19 PROJECTED GLOBAL COSTS FOR CANCER TREATMENTS, THROUGH 2014 ($ MILLIONS)
Treatment for Seniors
TABLE 20 PROJECTED U.S. MARKET FOR ALL TYPES OF CANCER TREATMENTS FOR INDIVIDUALS OVER 65, THROUGH 2014 ($MILLIONS)
DIABETES
Diabetes in the U.S.
International Prevalence
Origins of the Disease
Type 2 Diabetes
Complications of Diabetes
Barriers to Care in the U.S.
Diagnosing Diabetes

Chapter-7: INDUSTRY TRENDS BY SECTOR―HOUSING/PERSONAL CARE

TABLE 52 PROJECTED HOUSING MARKETS FOR SENIORS OVER 65, THROUGH 2014 ($ MILLIONS)
OPTIONS FOR HOUSING
REMODELING TO REMAIN AT HOME
TABLE 53 PROJECTED SPENDING ON HOME RENOVATION PROJECTS BY INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS)
COSTS OF AT-HOME SENIOR SERVICES CARE
TABLE 54 AVERAGE ANNUAL COST OF HOME CARE SERVICES, 2008 ($)
TABLE 55 PROJECTED MARKET FOR HOME CARE SERVICES, THROUGH 2014 ($ MILLIONS)
ADULT DAY CENTERS
ALTERNATIVE COMMUNITIES
Independent Living Communities
Recreationally Based Retirement Communities
Assisted Living
Costs for Assisted Living
TABLE 56 PROJECTED GROWTH OF ASSISTED-LIVING COSTS IN THE U.S. FOR INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS)
Nursing Care
Paying for Skilled Nursing Services
TABLE 57 PROJECTED MARKET FOR SKILLED NURSING FACILITIES FOR INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS)
Alzheimer’s Care
Costs of Alzheimer’s Care
UNPAID CAREGIVERS
PAID CAREGIVERS
Toll on Caregivers
LONG-TERM CARE
FIGURE 12 PROJECTED LIFETIME LONG-TERM CARE NEEDS FOR INDIVIDUALS OVER 65 (%)
END-OF-LIFE CONSIDERATIONS
Legal Matters
Hospice and Alzheimer’s
Hospice Costs and Alzheimer’s Disease
MARKET OPPORTUNITIES IN ELDERCARE HOME SERVICES AND HOUSING OPTIONS

Chapter-8: INDUSTRY TRENDS BY SECTOR―ASSISTIVE TECHNOLOGY

TABLE 58 PROJECTED U.S. ASSISTIVE TECHNOLOGY SALES FOR THE ELDERCARE MARKET, THROUGH 2014 ($ MILLIONS)
HOME SAFETY PRODUCTS/SERVICES
ACTIVITY LOCATION/PERSONAL MONITORING AIDS
Activity/Emergency Location Monitors
Remote Medical Monitors
TABLE 59 SELECTED MEDICAL/PERSONAL MONITORING AID MANUFACTURERS
MARKET GROWTH
TABLE 60 PROJECTED U.S. SALES OF MEDICAL/PERSONAL MONITORING AIDS FOR INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS)
MARKET DRIVERS
Market Fragmentation
DAILY LIVING AIDS
TABLE 61 SELECTED DAILY LIVING AIDS MANUFACTURERS
FIGURE 13 DAILY LIVING MARKET, BY SEGMENT AND TOTAL PERCENT OF SALES, 2007 (%)
FIGURE 14 PERCENT OF TOTAL SALES FOR OTHER DAILY LIVING AIDS, 2007 (%)
The Market for Daily Living Aids
TABLE 62 PROJECTED U.S. SALES OF DAILY LIVING AIDS FOR INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS)
Market Share by Company
TABLE 63 DAILY LIVING AIDS MANUFACTURERS, SALES AND PERCENT OF MARKET, 2007 ($ MILLIONS/PERCENT)
Incontinence Product Market
TABLE 64 PROJECTED U.S. SALES OF INCONTINENCE AND OSTOMY PRODUCTS, THROUGH 2014 ($ MILLIONS)
BATHING AIDS
Commode and Shower Chairs
TABLE 65 PROJECTED U.S. SALES OF COMMODE AND SHOWER CHAIRS TO INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS)
MOBILITY AIDS
TABLE 66 REPORTED INCIDENCE OF IMPAIRED MOBLITY AND DEXTERITY IN THE U.S. BY SEX/AGE GROUP, 2006 (%)
TABLE 67 PROJECTED U.S. MARKET FOR MOBILITY PRODUCTS FOR INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS)
AMBULATORY AIDS
TABLE 68 SELECTED AMBULATORY AID MANUFACTURERS
Ambulatory Aids Usage and Demographics
TABLE 69 PROJECTED U.S. SALES OF AMBULATORY AIDS FOR INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS)
WHEELCHAIR/SCOOTER USE
Medicare Reimbursement for Powered Wheelchairs
MARKET SHARE LEADERS
TABLE 70 SELECTED LIST OF WHEELCHAIR AND SCOOTER MANUFACTURERS
TABLE 71 WHEELCHAIR TYPES AND PERCENT OF MARKET, 2007 (%)
MARKET DRIVERS
TABLE 72 PROJECTED U.S, MARKET FOR WHEELCHAIR/SCOOTER MOBILITY PRODUCTS FOR THE ELDERLY, THROUGH 2014 ($ MILLIONS)
Special Purpose Wheelchairs
MOTOR VEHICLE CONVERSIONS
NAVIGATION AIDS
Ultrasound Guidance Systems
GPS Systems
TABLE 73 SELECTED NAVIGATION AIDS MANUFACTURERS
ACCESS AIDS
MARKET FOR ACCESS AIDS
TABLE 74 PROJECTED U.S. SALES OF ACCESS AID PRODUCTS BY SEGMENT, THROUGH 2014 ($ MILLIONS)
TABLE 75 PROJECTED U.S. SALES OF ACCESS AID PRODUCTS FOR INDIVIDUALS OVER 65, BY SEGMENT, THROUGH 2014 ($ MILLIONS)
HOME ELEVATORS
WHEELCHAIR LIFTS
STAIR CLIMBERS
ACCESSIBLE BATHS AND SHOWERS
SPECIAL COMMODES
BATH AND POOL LIFTS
TRANSFER LIFTS
DOOR OPENERS
TABLE 76 SELECTED ACCESS AID MANUFACTURERS
OTHER AIDS
TABLE 77 SELECTED MANUFACTURERS OF BED, SEATING, AND ERGONOMIC AIDS FOR THE ELDERLY
TABLE 78 PROJECTED MARKET FOR BEDS, SEATING SYSTEMS, AND ERGONOMIC AIDS FOR INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS)
Beds, Seating
Bariatric Beds
Seating and Positioning Systems
Ergonomic Aids
TABLE 79 EXAMPLES HAVE ERGONOMIC AIDS FOR THE ELDERLY
Computer Access Aids
Input Devices
Output Devices
Computer Software
TABLE 80 SELECTED COMPUTER AID MANUFACTURERS
ENVIRONMENTAL AIDS
TABLE 81 SELECTED ENVIRONMENTAL AID MANUFACTURERS
ASSISTIVE TECHNOLOGIES UNDER DEVELOPMENT

Chapter-9: COMPANY DIRECTORY

ABBOTT LABORATORIES
BUSINESS OVERVIEW
FINANCIALS
PRODUCTS
ASTRAZENECA PLC
BUSINESS OVERVIEW
FINANCIALS
PRODUCTS
BAY ADVANCED TECHNOLOGIES, LTD.
BUSINESS OVERVIEW
FINANCIALS
PRODUCTS
BAYER AG (MILES-BAYER)
BUSINESS OVERVIEW
FINANCIALS
PRODUCTS
BRISTOL-MYERS SQUIBB
BUSINESS OVERVIEW
FINANCIALS
PRODUCTS
BROOKDALE SENIOR LIVING
BUSINESS OVERVIEW
FINANCIALS
PRODUCTS
CENTOCOR
BUSINESS OVERVIEW
FINANCIALS
PRODUCTS
COVIDIEN
BUSINESS OVERVIEW
FINANCIALS
PRODUCTS
ELI LILLY
BUSINESS OVERVIEW
FINANCIALS
PRODUCTS
FOREST PHARMACEUTICALS
BUSINESS OVERVIEW
FINANCIALS
PRODUCTS
GENENTECH, INC.
BUSINESS OVERVIEW
FINANCIALS
PRODUCTS
GLAXOSMITHKLINE PLC
BUSINESS OVERVIEW
FINANCIALS
PRODUCTS
GRAHAM-FIELD HEALTH PRODUCTS
BUSINESS OVERVIEW
FINANCIALS
PRODUCTS
HONEYWELL HOMMED, LLC
BUSINESS OVERVIEW
FINANCIALS
PRODUCTS
HUMANWARE
FINANCIALS
PRODUCTS
INVACARE CORP.
BUSINESS OVERVIEW
FINANCIALS
PRODUCTS
JOHNSON & JOHNSON
BUSINESS OVERVIEW
FINANCIAL INFORMATION
PRODUCTS
KIMBERLY CLARK
BUSINESS OVERVIEW
FINANCIALS
PRODUCTS
KINDRED HEALTHCARE
BUSINESS OVERVIEW
FINANCIALS
PRODUCTS
LIFE ALERT EMERGENCY RESPONSE

Chapter-10: APPENDIX

APPENDIX
DEFINITIONS
ACTIVITIES OF DAILY LIVING (ADLS)
ALZHEIMER’S DISEASE
ARTHRITIS
ASSISTIVE TECHNOLOGY
ASSISTED LIVING
BABY BOOMER
CAREGIVERS
CARDIOVASCULAR DISEASE (CVD)
CONGESTIVE OBSTRUCTIVE PULMONARY DISEASE (COPD)
DEMENTIA
DIABETES
DURABLE MEDICAL EQUIPMENT
ELDER/SENIOR
GERONTOLOGY
HOSPICE CARE
INSTRUMENTAL ACTIVITIES OF DAILY LIVING (IADL)
LONG-TERM CARE
PROSTHETICS AND ORTHOTICS